Nathalie Boiret‐Dupré

Author

Centre Hospitalier Universitaire de Clermont-Ferrand ORCID

Also Known As

Boiret-Dupré, N., N Boiret-Dupré, N. Boiret-Dupre, N. Boiret-Dupré, Nathalie Boiret-Dupre, Nathalie Boiret-Dupré, Nathalie Boiret-Dupré, Nathalie Boiret‐Dupre, Nathalie Boiret‐Dupré

Publications

491

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Clermont-Ferrand Inserm Hôpital Saint-Louis Université Clermont Auvergne Université Paris Cité

About

Nathalie Boiret‐Dupré is an author at Centre Hospitalier Universitaire de Clermont-Ferrand specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	109
2	Cell Biology	4	4	109
3	Immunology	3	3	96
4	Health Sciences	2	2	31
5	Cellular Therapies	2	2	58

Nathalie Boiret‐Dupré

Publications

439

Citations

H-Index

Page 1

	Year	Citations
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera Éric Lippert, Marjorie Boissinot, Róbert Královics, Blood	2006	233
Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy Richard Veyrat‐Masson, Nathalie Boiret‐Dupré, Chantal Rapatel, British Journal of Haematology	2007	62
Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell Research Marc Berger, Richard Veyrat‐Masson, Chantal Rapatel, Stem Cells Cell TherapyNative MscAdult Stem CellImmunologyPreliminary Amplification	2006	45
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an <i>in vitro</i> model of Gaucher disease Juliette Berger, Séverine Lecourt, Valérie Vanneaux, British Journal of Haematology ImmunologyBlood CellPathologySignificant Glcc ActivityImmunotherapy	2010	33
Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a −80°C mechanical freezer and preserved less than 6 months Laure Calvet, Aurélie Cabrespine, Nathalie Boiret‐Dupré, Transfusion	2012	18
The Chronic Lymphocytic Leukemia Clone Disrupts the Bone Marrow Microenvironment Alexandre Janel, Frédérique Dubois-Galopin, Céline Bourgne, Stem Cells and Development ImmunologyCell DeathBone Marrow MicroenvironmentTumor BiologyMyeloid Neoplasia	2014	18
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX Vincent Jachiet, Olivier Kosmider, Maxime Beydon, Blood	2025	17
Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit? Étienne Merlin, Sarah Zohar, Cécile Jérome, Bone Marrow Transplantation Cell TherapyPediatric HematologyStem Cell MobilizationHematologyCell Replacement Therapy	2008	13

Page 1